Top 4 Low-cap Layer 1 Altcoins To Focus on in 2024

1. Radiant (RXD)

Radiant is a peer-to-peer digital asset system that enables direct value exchange without a central authority. It uses a minimal structure, similar to Bitcoin, and timestamps transactions into a continuous proof-of-work chain.

- Current Price: $0.000716 (up 8.99% in the last 24 hours)

- Market Cap: $7.971 million

- 24-Hour Trading Volume Increase: 117.89%

- All-Time High: $0.009245 (April 15, 2023, down 92.24%)

- All-Time Low: $0.0004307 (February 13, 2023, up 66.46%)

Despite a declining trend, RXD is ready for a potential bull cycle. A move from the support trendline could see a rise to $0.0024, indicating a 250% upside potential.

2. Chromia (CHR)

Chromia is a blockchain platform developed by ChromaWay, designed to simplify the creation of decentralized applications (DApps). It has been active since 2014 and is known for developing colored coins that represent various assets on a blockchain.

- Current Price: $0.2407 (up 4.27% in the last 24 hours)

- Market Cap: $195.5 million

- 24-Hour Trading Volume Increase: 381%

- All-Time High: $1.50 (down 84%)

- All-Time Low: $0.008525 (up 2705.75%)

According to Fibonacci levels, a price jump from $0.21 could reach $0.8435.

3. Injective Protocol (INJ)

Injective is a blockchain platform designed to revolutionize finance through its advanced Layer 1 infrastructure. Recently, INJ showed a notable reversal from support at $18.6 and the 100-week EMA.

- Current Price: $22.4 (up 20% in the recent recovery)

- Market Cap: $2.077 billion

If bullish momentum continues, INJ could challenge the overhead trendline at $27. A breakout here could signal a trend reversal and push the price toward $53.

4. Dione Protocol (DIONE)

Dione Protocol focuses on creating a sustainable and eco-friendly digital economy by leveraging renewable energy sources.

- Current Price: $0.0082 (up 16.4% after stabilizing above the 38.2% Fibonacci retracement level)

- Market Cap: $77.6 million

If buying pressure continues, DIONE could flip the 200-day EMA into support.